Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Christine analogues that inhibit the FTSZ protein

A technology of drugs and compounds, applied in the field of antimicrobial compounds, which can solve problems such as the rising prevalence of invasive infections

Inactive Publication Date: 2015-10-14
UNITED STATES OF AMERICA +1
View PDF24 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, the prevalence of invasive infections has been reported to rise as the number of patients infected with HIV, treated with cancer therapy, or treated with broad-spectrum antibiotics increases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Christine analogues that inhibit the FTSZ protein
  • Christine analogues that inhibit the FTSZ protein
  • Christine analogues that inhibit the FTSZ protein

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0216] Compound Isolation and Structure Determination

[0217] Samples of the Chrysophaeum taylori algae were collected from 20 ft below the surface in Round Bay, St. John's Island (Lewis and Bryan, Am. J. Bot., 28:343, 1941). The algae, which is found growing in fluffy colonies on coarse sand or crushed coral substrates, exhibits a sulfur yellow color and can turn rusty brown within seconds when disturbed. The multicellular structure of C. taylori is extremely fragile, and the sticky cells are not well preserved. However, when freshly collected or freshly preserved (2.5% glutaraldehyde in seawater) samples were viewed under a light microscope, stalk-like structures consisting of branched slime "ribbons" of pyriform embedded cells could be seen. In addition, algae collections contained the known styrylchromone hormothamnione and showed remarkable similarities to field records published by Gerwick (J. Nat. Prod., 52:252, 1989) at all stages of manipulation.

[0218] Antimicro...

Embodiment 2

[0253]Antimicrobial tests of compounds 1, 1a, 4-8

[0254] Compounds 1-8 were tested against Staphylococcus aureus (SA, ATCC25923), methicillin-resistant Staphylococcus aureus (MRSA, ATCC BAA-41), Antimicrobial activity of multidrug-resistant Staphylococcus aureus (MDRSA, ATCC BAA-44), Enterococcus faecium (EF, ATCC49032), vancomycin-resistant Enterococcus faecium (VRE, ATCC700221) and Bacillus subtilis (ATCC49343). For the plate diffusion assay, agar plates inoculated with the bacterial suspension were prepared by adding 500 μL of the bacterial culture grown for 24 h to 100 mL of autoclaved and cooled to 55° C. Mueller Hinton II agar. The inoculated liquid agar (10 mL) was immediately transferred to a square petri dish and allowed to cool for 1 h. Control drugs for each microorganism included kanamycin (50 μg) for S. aureus and nitrofurantoin (25 μg) for MRSA. After incubation for 18 h at 37°C, the zone of inhibition was measured. The MICs of compounds 1 and 4-8 were deter...

Embodiment 3

[0262] GTPase activity and FtsZ polymerization

[0263] The bacterial cytoskeletal protein FtsZ is a GTPase and shares structural homology with the eukaryotic cytoskeletal protein tubulin, but lacks significant sequence similarity. FtsZ is essential for bacterial cell division. Non-cleavable GTP analogs have been reported to inhibit FtsZ in vitro, as do several small molecules. Inhibition of FtsZ terminates bacterial cell division and is a potent target for new antimicrobial agents. Compound 1 was tested for its ability to inhibit the GTPase activity of recombinant Escherichia coli FtsZ using a colorimetric assay that detects inorganic molybdenum released upon hydrolysis of GTP to GDP by complexation with molybdate (also known as malachite green). Phosphate (P i ). GTPase assay in 50mM MES, pH6.5, 50mM KCI, 5mMMgCl 2 in the presence of 2 μM FtsZ and different concentrations of compound 1. The solution was incubated at room temperature for 5 min before adding 0.25 mM GTP....

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Embodiments of antimicrobial chrysophaentin compounds, pharmaceutical compositions including the chrysophaentin compounds, methods for using the chrysophaentin compounds, and methods for synthesizing the chrysophaentin compounds are disclosed. Certain embodiments of the chrysophaentin compounds inhibit FtsZ protein, thereby inhibiting the growth of clinically relevant bacteria, including drug-resistant strains.

Description

[0001] Cross References to Related Applications [0002] This application claims the benefit of US Provisional Application No. 61 / 446,978, filed February 25, 2011, which is hereby incorporated by reference in its entirety. technical field [0003] The present disclosure generally relates to antimicrobial compounds and methods of their use. Background technique [0004] There is a continuing need to identify new lead compounds with novel mechanisms of action to treat infections caused by multidrug resistant bacteria. Infectious diseases are the leading cause of death worldwide, and it is estimated that in the United States, more people die from infections associated with methicillin-resistant Staphylococcus aureus (MRSA) than from HIV. In addition, the prevalence of invasive infections has been reported to rise as the number of patients infected with HIV, treated with cancer therapy, or treated with broad-spectrum antibiotics increases. In fact, 90,000 people die each year ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07C15/50C07C17/266C07C25/24C07C41/05C07C43/275C07C43/285C07C43/295A61K31/085
CPCC07C37/14A61K31/055A61K31/085A61K45/06C07C39/373C07C43/23C07D321/00Y02A50/30
Inventor 卡罗勒·A·比利彼得·威普弗
Owner UNITED STATES OF AMERICA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com